BioSpace News Archive

Thorne HealthTech, Inc. announced today that it will participate in the Canaccord Genuity 43rd Annual Growth Conference in Boston.

SK bioscience today released its 2023 Environmental, Social and Governance (ESG) Report.

Adamis Pharmaceuticals Corporation today announced the Company has committed to fund an unrestricted research grant to the Leiden University Medical Center (LUMC) Anesthesia and Pain Research Unit.

Argon Medical Devices, a leading manufacturer of medical devices for interventional procedures, announces recognition as a 2023 Top Workplace in the USA Manufacturing sector.

In a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s The Feinstein Institutes for Medical Research have successfully implanted microchips into the brain of a man living with paralysis, and have developed artificial intelligence algorithms to re-link his brain to his body and spinal cord.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2023 financial results on Thursday, August 3rd, 2023 after the markets close.

Chinook Therapeutics, Inc. today announced that the first patient with IgA nephropathy (IgAN) has been enrolled in the BEYOND study, a pivotal phase 3 clinical trial evaluating the safety and efficacy of zigakibart (BION-1301), a potentially disease-modifying anti-APRIL monoclonal antibody.

Apollo Medical Holdings, Inc. announced that it will release financial results for the second quarter ended June 30, 2023, after the close of the stock market on Monday, August 7, 2023.

OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant unmet need in this multi-billion-dollar market, announced that it intends to offer to sell its ordinary shares in an underwritten public offering.